Loratadine Switch Profitable For Payers, Consumers – Study
This article was originally published in The Tan Sheet
Executive Summary
The Rx-to-OTC switch of loratadine has resulted in a decrease in prescription antihistamine use and cost, a study published in the June American Journal of Managed Care finds
You may also be interested in...
CDHPs Boost Self-Care, Reduce Health Services Use – McKinsey Report
Consumer-directed health plans (CDHPs) such as Health Savings Accounts are encouraging consumer involvement in self-care and preventative treatments, a recent report from McKinsey & Co. finds
CDHPs Boost Self-Care, Reduce Health Services Use – McKinsey Report
Consumer-directed health plans (CDHPs) such as Health Savings Accounts are encouraging consumer involvement in self-care and preventative treatments, a recent report from McKinsey & Co. finds
CDHPs Boost Self-Care, Reduce Health Services Use – McKinsey Report
Consumer-directed health plans (CDHPs) such as Health Savings Accounts are encouraging consumer involvement in self-care and preventative treatments, a recent report from McKinsey & Co. finds